BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7742549)

  • 1. Overexpression of cyclin D2 in chronic B-cell malignancies.
    Delmer A; Ajchenbaum-Cymbalista F; Tang R; Ramond S; Faussat AM; Marie JP; Zittoun R
    Blood; 1995 May; 85(10):2870-6. PubMed ID: 7742549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
    Decker T; Schneller F; Hipp S; Miething C; Jahn T; Duyster J; Peschel C
    Leukemia; 2002 Mar; 16(3):327-34. PubMed ID: 11896535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective usage of D-type cyclins in lymphoid malignancies.
    Suzuki R; Kuroda H; Komatsu H; Hosokawa Y; Kagami Y; Ogura M; Nakamura S; Kodera Y; Morishima Y; Ueda R; Seto M
    Leukemia; 1999 Sep; 13(9):1335-42. PubMed ID: 10482983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma.
    de Boer CJ; van Krieken JH; Kluin-Nelemans HC; Kluin PM; Schuuring E
    Oncogene; 1995 May; 10(9):1833-40. PubMed ID: 7753558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia.
    Wolowiec D; Ciszak L; Kosmaczewska A; Bocko D; Teodorowska R; Frydecka I; Kuliczkowski K
    Haematologica; 2001 Dec; 86(12):1296-304. PubMed ID: 11726322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 expression in mantle cell lymphoma is accompanied by downregulation of cyclin D3 and is not related to the proliferative activity.
    Ott MM; Bartkova J; Bartek J; Dürr A; Fischer L; Ott G; Müller-Hermelink HK; Kreipe H
    Blood; 1997 Oct; 90(8):3154-9. PubMed ID: 9376597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.
    Solvason N; Wu WW; Kabra N; Wu X; Lees E; Howard MC
    J Exp Med; 1996 Aug; 184(2):407-17. PubMed ID: 8760794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia.
    Pabst T; Peters UR; Tinguely M; Schwaller J; Tschan M; Aebi S; Vonlanthen S; Borisch B; Betticher DC; Zimmermann A; Tobler A; Fey MF
    Leuk Lymphoma; 2000 May; 37(5-6):639-48. PubMed ID: 11042528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 in B-cell lymphocytic proliferative diseases.
    Cao X; Fan L; Fang C; Zhu DX; Dong HJ; Wang DM; Wang YH; Xu W; Li JY
    Med Oncol; 2012 Jun; 29(2):1190-6. PubMed ID: 21479697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cyclin D1 protein in centrocytic/mantle cell lymphomas with and without rearrangement of the BCL1/cyclin D1 gene.
    Swerdlow SH; Yang WI; Zukerberg LR; Harris NL; Arnold A; Williams ME
    Hum Pathol; 1995 Sep; 26(9):999-1004. PubMed ID: 7545645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cyclins D1, D2, and D3 and Ki-67 in Leukemia.
    Jaroslav P; Martina H; Jirí S; Hana K; Petr S; Tomás K; Julius M; Cedrik H
    Leuk Lymphoma; 2005 Nov; 46(11):1605-1612. PubMed ID: 16334487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of cyclin D1 (bcl-1, PRAD1) overexpression by a simple competitive reverse transcription-polymerase chain reaction assay in t(11;14)(q13;q32)-bearing B-cell malignancies and/or mantle cell lymphoma.
    Uchimaru K; Taniguchi T; Yoshikawa M; Asano S; Arnold A; Fujita T; Motokura T
    Blood; 1997 Feb; 89(3):965-74. PubMed ID: 9028328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ hybridization detection of cyclin D1 mRNA in centrocytic/mantle cell lymphoma.
    Williams ME; Nichols GE; Swerdlow SH; Stoler MH
    Ann Oncol; 1995 Mar; 6(3):297-9. PubMed ID: 7612496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of G1-phase arrest induced by ionizing radiation in hematopoietic cells by overexpression of genes involved in the G1/S-phase transition.
    Epperly M; Berry L; Halloran A; Greenberger JS
    Radiat Res; 1995 Sep; 143(3):245-54. PubMed ID: 7652161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases.
    Sanhes L; Tang R; Delmer A; DeCaprio JA; Ajchenbaum-Cymbalista F
    Leukemia; 2003 Jun; 17(6):1104-11. PubMed ID: 12764376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of G1-->S transition regulatory molecules in human urothelial cancer.
    Oya M; Schmidt B; Schmitz-Dräger BJ; Schulz WA
    Jpn J Cancer Res; 1998 Jul; 89(7):719-26. PubMed ID: 9738978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cyclins D1, D2 and E correlates with proliferation of rat stellate cells in culture.
    Kawada N; Ikeda K; Seki S; Kuroki T
    J Hepatol; 1999 Jun; 30(6):1057-64. PubMed ID: 10406184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D expression in chronic lymphocytic leukemia.
    Paul JT; Henson ES; Mai S; Mushinski FJ; Cheang M; Gibson SB; Johnston JB
    Leuk Lymphoma; 2005 Sep; 46(9):1275-85. PubMed ID: 16109604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes.
    Ajchenbaum F; Ando K; DeCaprio JA; Griffin JD
    J Biol Chem; 1993 Feb; 268(6):4113-9. PubMed ID: 8382693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D2 promoter disrupted by t(12;22)(p13;q11.2) during transformation of chronic lymphocytic leukaemia to non-Hodgkin's lymphoma.
    Qian L; Gong J; Liu J; Broome JD; Koduru PR
    Br J Haematol; 1999 Aug; 106(2):477-85. PubMed ID: 10460609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.